| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 6.59▲ | 6.45▲ | 6.45▲ | 6.47▲ | 7.62▼ |
| MA10 | 6.34▲ | 6.26▲ | 6.26▲ | 7.33▼ | 7.78▼ |
| MA20 | 6.37▲ | 6.34▲ | 6.29▲ | 7.81▼ | 10.73▼ |
| MA50 | 6.40▲ | 7.23▼ | 7.35▼ | 8.21▼ | 9.71▼ |
| MA100 | 7.33▼ | 7.88▼ | 8.05▼ | 11.20▼ | 14.44▼ |
| MA200 | 7.92▼ | 8.54▼ | 9.37▼ | 10.08▼ | 2,107.44▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.103▲ | 0.126▲ | 0.128▲ | -0.131▼ | -0.393▼ |
| RSI | 63.891▲ | 56.512▲ | 54.234▲ | 43.325▼ | 42.566▼ |
| STOCH | 83.154▲ | 51.365 | 48.148 | 8.681▼ | 18.300▼ |
| WILL %R | 0.000▲ | 0.000▲ | 0.000▲ | -76.508▼ | -86.781▼ |
| CCI | 178.180▲ | 183.572▲ | 176.693▲ | -83.230 | -109.457▼ |
|
Thursday, March 26, 2026 06:26 AM
Secures Orphan Drug Designations for QRX003 for Netherton Syndrome (NS) in the U.S. and Europe – Advances Proposed Expedited Regulatory Approval Pathways in Japan and Saudi Arabia and Secures Fast ...
|
|
Wednesday, March 25, 2026 08:07 AM
Quoin Pharmaceuticals (NASDAQ:QNRX) said it received encouraging regulatory feedback from the U.S. Food and Drug Administration (FDA) following a Type C meeting held on March 25, 2026 regarding the ...
|
|
Wednesday, March 25, 2026 06:53 AM
FDA indicated that a single Phase 3 study may be sufficient to support marketing approval in the U.S. FDA expressed openness to an alternative study design for Phase 3 that would likely not include a ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 02/04/26 | 5.8501 | 7.03 | 5.8501 | 7.02 | 58,402 |
| 01/04/26 | 6.60 | 7.09 | 5.95 | 6.06 | 59,429 |
| 31/03/26 | 6.28 | 6.97 | 6.22 | 6.60 | 142,301 |
| 30/03/26 | 6.4669 | 6.5075 | 5.9767 | 6.28 | 43,454 |
| 27/03/26 | 7.25 | 7.41 | 6.41 | 6.41 | 74,770 |
| 26/03/26 | 9.33 | 9.33 | 7.31 | 7.565 | 174,627 |
| 25/03/26 | 9.92 | 10.83 | 7.68 | 9.27 | 4,112,792 |
| 24/03/26 | 8.055 | 8.055 | 8.00 | 8.00 | 2,774 |
| 23/03/26 | 7.96 | 8.18 | 7.96 | 8.16 | 5,746 |
| 20/03/26 | 7.965 | 8.16 | 7.80 | 7.941 | 11,902 |
|
|
||||
|
|
||||
|
|